230 related articles for article (PubMed ID: 34950585)
21. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of pleural fluid to serum carcinoembryonic antigen ratio and delta value for malignant pleural effusion: findings from two cohorts.
Jiang MP; Wen JX; Hai L; Jiang TW; Huang JH; Chen H; Wang YF; Zheng WQ; Hu ZD; Yan L
Ther Adv Respir Dis; 2023; 17():17534666231155745. PubMed ID: 36927281
[TBL] [Abstract][Full Text] [Related]
24. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
[TBL] [Abstract][Full Text] [Related]
25. Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on
Li Y; Mu W; Li Y; Song X; Huang Y; Jiang L
EJNMMI Res; 2021 Oct; 11(1):108. PubMed ID: 34652524
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion.
Santotoribio JD; Del Valle-Vazquez L; García-de la Torre A; Del Castillo-Otero D; Lopez-Saez JB; Sanchez Del Pino MJ
PLoS One; 2019; 14(9):e0222616. PubMed ID: 31550262
[TBL] [Abstract][Full Text] [Related]
28. Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test.
Cha SN; Niu Y; Wen JX; Yan C; Yang Q; Zhu HZ; Lin X; Cao XS; Gao WH; Wang YF; Zhou F; Yan L; Zheng WQ; Hu ZD
Transl Lung Cancer Res; 2024 May; 13(5):1061-1068. PubMed ID: 38854948
[TBL] [Abstract][Full Text] [Related]
29. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
30. Novel clinical radiomic nomogram method for differentiating malignant from non-malignant pleural effusions.
Han R; Huang L; Zhou S; Shen J; Li P; Li M; Wu X; Wang R
Heliyon; 2023 Jul; 9(7):e18056. PubMed ID: 37539225
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.
Sharma SK; Bhat S; Chandel V; Sharma M; Sharma P; Gupta S; Sharma S; Bhat AA
J Carcinog; 2015; 14():7. PubMed ID: 26900349
[TBL] [Abstract][Full Text] [Related]
32. Combination of long noncoding RNA
Wang WW; Zhou XL; Song YJ; Yu CH; Zhu WG; Tong YS
Onco Targets Ther; 2018; 11():2333-2344. PubMed ID: 29731641
[TBL] [Abstract][Full Text] [Related]
33. Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.
Li Y; Chen Z; Yang P; Duan H; He J; Gong L; Zhao L
J Thorac Dis; 2023 May; 15(5):2627-2635. PubMed ID: 37324069
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
35. Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods.
Darooei R; Sanadgol G; Gh-Nataj A; Almasnia M; Darivishi A; Eslaminejad A; Raoufy MR
Tanaffos; 2017; 16(2):157-165. PubMed ID: 29308081
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
Lin L; Li S; Xiong Q; Wang H
BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
[TBL] [Abstract][Full Text] [Related]
37. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
[TBL] [Abstract][Full Text] [Related]
39. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and comparative performance for the prediction of tuberculous pleural effusion using machine learning algorithms.
Liu Y; Liang Z; Yang J; Yuan S; Wang S; Huang W; Wu A
Int J Med Inform; 2024 Feb; 182():105320. PubMed ID: 38118260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
